Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.667 | 0.560 | 18 | 671384 | missense variant | G/A;C | snv | 4.0E-06 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||||
|
0.827 | 0.120 | 18 | 675307 | intron variant | A/G | snv | 4.5E-02 | 3.6E-02 |
|
Neoplasms; Respiratory Tract Diseases | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||
|
0.827 | 0.120 | 18 | 675307 | intron variant | A/G | snv | 4.5E-02 | 3.6E-02 |
|
Pathological Conditions, Signs and Symptoms; Neoplasms | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||
|
0.827 | 0.120 | 18 | 675307 | intron variant | A/G | snv | 4.5E-02 | 3.6E-02 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||
|
0.827 | 0.120 | 18 | 675307 | intron variant | A/G | snv | 4.5E-02 | 3.6E-02 |
|
Neoplasms; Respiratory Tract Diseases | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||
|
0.827 | 0.120 | 18 | 675307 | intron variant | A/G | snv | 4.5E-02 | 3.6E-02 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||
|
0.827 | 0.120 | 18 | 675307 | intron variant | A/G | snv | 4.5E-02 | 3.6E-02 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications | 0.010 | 1.000 | 1 | 2009 | 2009 | ||||||
|
0.827 | 0.120 | 18 | 675307 | intron variant | A/G | snv | 4.5E-02 | 3.6E-02 |
|
Neoplasms; Respiratory Tract Diseases | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||
|
0.827 | 0.120 | 18 | 675307 | intron variant | A/G | snv | 4.5E-02 | 3.6E-02 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications | 0.010 | 1.000 | 1 | 2009 | 2009 | ||||||
|
0.882 | 0.120 | 18 | 676008 | intron variant | G/C | snv | 0.63 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases | 0.020 | 1.000 | 2 | 2010 | 2018 | |||||||
|
0.882 | 0.120 | 18 | 676008 | intron variant | G/C | snv | 0.63 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases | 0.020 | 1.000 | 2 | 2010 | 2018 | |||||||
|
0.882 | 0.120 | 18 | 676008 | intron variant | G/C | snv | 0.63 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases | 0.020 | 1.000 | 2 | 2010 | 2018 | |||||||
|
0.882 | 0.160 | 18 | 683607 | intron variant | C/T | snv | 0.63 |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||||
|
0.882 | 0.160 | 18 | 683607 | intron variant | C/T | snv | 0.63 |
|
Digestive System Diseases; Neoplasms | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.882 | 0.160 | 18 | 683607 | intron variant | C/T | snv | 0.63 |
|
Digestive System Diseases; Neoplasms | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.882 | 0.120 | 18 | 676008 | intron variant | G/C | snv | 0.63 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||||
|
0.925 | 0.080 | 18 | 672792 | 3 prime UTR variant | C/T | snv | 0.40 |
|
Neoplasms | 0.020 | 1.000 | 2 | 2019 | 2019 | |||||||
|
0.925 | 0.080 | 18 | 676789 | intron variant | A/T | snv | 0.15 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications | 0.010 | 1.000 | 1 | 2009 | 2009 | |||||||
|
0.925 | 0.080 | 18 | 676789 | intron variant | A/T | snv | 0.15 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications | 0.010 | 1.000 | 1 | 2009 | 2009 | |||||||
|
0.925 | 0.080 | 18 | 672792 | 3 prime UTR variant | C/T | snv | 0.40 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||||
|
0.925 | 0.040 | 18 | 673444 | 3 prime UTR variant | AAGTTA/-;AAGTTAAAGTTA | delins |
|
Stomatognathic Diseases | 0.010 | < 0.001 | 1 | 2018 | 2018 | ||||||||
|
0.925 | 0.040 | 18 | 673444 | 3 prime UTR variant | AAGTTA/-;AAGTTAAAGTTA | delins |
|
Nutritional and Metabolic Diseases | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||||
|
0.925 | 0.040 | 18 | 673444 | 3 prime UTR variant | AAGTTA/-;AAGTTAAAGTTA | delins |
|
Stomatognathic Diseases | 0.010 | < 0.001 | 1 | 2018 | 2018 | ||||||||
|
0.925 | 0.080 | 18 | 677931 | intron variant | C/G | snv | 0.22 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications | 0.010 | 1.000 | 1 | 2009 | 2009 | |||||||
|
0.925 | 0.080 | 18 | 677931 | intron variant | C/G | snv | 0.22 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications | 0.010 | 1.000 | 1 | 2009 | 2009 |